figshare
Browse
12962_2017_81_MOESM1_ESM.docx (17.47 kB)

MOESM1 of Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates

Download (17.47 kB)
journal contribution
posted on 2017-09-07, 05:00 authored by Stephanie Harvard, Daphne Guh, Nick Bansback, Pascal Richette, Alain Saraux, Bruno Fautrel, Aslam Anis
Additional file 1: Table S1. Characteristics of anti-TNF users not satisfying selected criteria sets.

Funding

Spondyloarthritis Research Consortium of Canada

History

Usage metrics

    Cost Effectiveness and Resource Allocation

    Categories

    Keywords

    Cost-effectivenessAnti-TNFBiologicsPharmaceutical policySpondyloarthritis

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC